Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Mild cognitive impairment Stories

Meditation May Help Slow Progression Of Alzheimer's Disease
2013-11-19 06:28:41

redOrbit Staff & Wire Reports - Your Universe Online The biological changes and stress-level reduction caused by meditation could help slow the progression of Alzheimer’s disease or other age-related neurodegenerative conditions, researchers from the Beth Israel Deaconess Medical Center (BIDMC) in Boston claim in a recently-published pilot study. “We know that approximately 50 percent of people diagnosed with mild cognitive impairment – the intermediate stage between the...

Alzheimer's Patients May Benefit From Novel Herbal Extracts
2013-11-16 05:41:04

redOrbit Staff & Wire Reports - Your Universe Online A concoction made out of special antioxidants found in rosemary and spearmint has been found to improve learning and memory, and could potentially help combat Alzheimer’s disease, researchers from the Saint Louis University School of Medicine have discovered. In research presented this week at Neuroscience 2013, the researchers explained that they tested a novel antioxidant-based ingredient made from spearmint extract, as well...

2013-11-12 12:07:07

Using scores obtained from cognitive tests, Johns Hopkins researchers think they have developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer's disease. The risk of developing dementia increases markedly when a person is diagnosed with mild cognitive impairment, a noticeable and measurable decline in intellectual abilities that does not seriously interfere with daily life. But physicians have no reliable way to predict...

2013-10-24 23:04:24

Reportbuyer.com just published a new market research report: PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022. London (PRWEB) October 24, 2013 PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so...

2013-10-17 11:44:14

Johns Hopkins researchers identify biomarkers in spinal fluid Johns Hopkins researchers say that by measuring levels of certain proteins in cerebrospinal fluid (CSF), they can predict when people will develop the cognitive impairment associated with Alzheimer's disease years before the first symptoms of memory loss appear. Identifying such biomarkers could provide a long-sought tool to guide earlier use of potential drug treatments to prevent or halt the progression of Alzheimer's while...

Peanut Butter Test For Alzheimer's
2013-10-11 10:22:20

[ Watch The Video: 'Peanut Butter Test' Can Help Diagnose Alzheimer's ] Brett Smith for redOrbit.com - Your Universe Online Researchers at the University of Florida have developed a quick, cheap and easy way to confirm a diagnosis of Alzheimer's disease or mild cognitive impairment by simply using a spoonful of peanut butter and a ruler, according to a new study in the Journal of the Neurological Sciences. The Florida research team found that individuals with mild cognitive...

2013-10-07 08:25:05

MONTREAL, Oct. 7, 2013 /CNW/ - Results from two new studies add to the body of evidence that supports Cognigram(TM) as a sensitive assessment to detect and monitor cognitive decline over time, namely in healthy individuals and adults with mild cognitive impairment (MCI) that are carriers of a biological marker in the brain - Ab amyloid.(1,2) Data from two studies were presented at the Canadian Conference on Dementia (CCD), in Vancouver, British Columbia, between October 3 and 5....

2013-10-02 12:51:46

Results presented at World Parkinson Congress Researchers at the University of Montreal and the Institut universitaire de gératrie de Montréal examined brain changes over 20 months in Parkinson's patients with and without mild cognitive impairment (MCI) at the early stages of the disease. Results showed that patients with MCI had significantly more cortical thinning and subcortical atrophy over time compared with patients without MCI, suggesting that early MCI in PD patients may indicate...

2013-09-30 08:31:09

Latest Financing to Accelerate Development of Alzheimer's Drug GRAND RAPIDS, Mich., Sept. 30, 2013 /PRNewswire/ -- Tetra Discovery Partners, a leader in the design of new therapeutics for major neurological conditions based on PDE4 modulation in the brain, today announced it has closed a $1,041,000 seed investment led by Grand Angels, a Grand Rapids, Mich.-based investment group. The investment in Tetra includes funding from Grand Angels and the Biosciences Research &...

2013-09-25 23:34:16

Nationwide study to help determine whether two research-tested strategies can work together to improve cognitive functioning in adults with Mild Cognitive Impairment (MCI}. Richmond, VA (PRWEB) September 25, 2013 Researchers at the University of Sydney, Australia, have announced the start of a large-scale study to investigate the effectiveness of combining two promising interventions in helping to combat age-related cognitive decline leading to dementia. Research suggests that the...